US Food and Drug Administration

Tech mogul Elon Musk made a groundbreaking announcement on Monday, revealing that the first human recipient of Neuralink's brain-chip implant underwent a successful procedure on Sunday and is on the path to recovery.

Pharmathen pharmaceuticals has acquired CBL Patras peptide material suppliers, it was reported on Monday. 

Approved by the US Food and Drug Administration (FDA), Pharmathen specializes in one of the most extensive and technologically advanced pipelines in long-acting injectables (LAI), sustained release formulations and preservative-free ophthalmics. 

The approval by the US Food and Drug Administration last Thursday of the antibody treatment Leqembi, which significantly slows the progression of Alzheimer's in its early stages, has given hope to millions of patients and their families. 

The drug is the fruit of the collaboration between American biotechnology company Biogen and Japan's Eisai.

In 1937, an American drug company introduced an elixir to treat strep throat - and unwittingly set off a public health disaster. The product, which had not been tested in humans or animals, contained a solvent that turned out to be toxic. More than 100 people died.

The US Food and Drug Administration on Jan. 6 approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

As of December 6, all citizens, regardless of their vaccination status, arriving in the United States by air must submit a negative NAA test (including PCR) or antigen test to the airline within 24 hours prior to boarding, announced the press center of the Bulgarian Ministry of Foreign Affairs.

The pharmaceutical company Pfizer has asked the US Food and Drug Administration to allow the third dose of Covid-19 vaccine for anyone over 18 years of age.

The argument is that more protection is needed and that there is a danger of increasing the spread of the virus with holiday trips and gatherings.

The British-Swedish pharmaceutical company AstraZeneca has requested an extraordinary permit for the use in the United States of its latest drug, which prevents COVID-19 disease. The drug, currently called AZD7442, is intended for people with weak immune systems, which would make vaccination ineffective.

It will be implemented at least six months after the second

The US Food and Drug Administration has supported the use of a booster dose of Pfizer's COVID-19 vaccine for people over the age of 65 and for some high-risk patients. The decision is to be voted on by the Board of the Centers for Control and Prevention. Most likely this will happen today.

The US Food and Drug Administration (FDA) has given its full approval to the use of the Pfizer / BioNTech vaccine in the United States. Although the vaccine has been given so far, this has only happened with an "emergency" authorization.

The two-dose vaccine has met "the high standard of safety, efficiency and quality of production," said acting FDA director Janet Woodstock.